United Kingdom

Baseimmune secures €10.4M Series A to develop AI-Predicted Mutation-Proof Vaccines
Baseimmune, a London-based biotech leveraging deep learning AI to predict pathogen mutations for vaccine development, has raised $11.3M (approximately €10.40M) in a Series A funding round. The investment was led by new investors MSD Global Health Innovation Fund and IQ Capital, with participation from existing backers such as Hoxton Ventures, Creator Fund, Beast Ventures, and Maki.vc.
Napier AI, a London-based regtech company specializing in AI-powered anti-money laundering and financial crime compliance software, has announced a significant funding round of £45M (approximately €52M) from Crestline Investors. This capital injection will enable Napier AI to expand its business and continue developing NextGen screening and monitoring solutions for financial
docStribute, a London-based RegTech company, has announced the successful closure of a £820K (approximately €960K) pre-Series A funding round, led by financial service angels. This latest funding brings the company's total raised capital to over £1.7M (approximately €1.9M), marking a significant step forward in its mission to revolutionize customer communication
Episode 1, a venture capital firm based in London, has successfully closed its third early-stage fund at £76 million (approximately €88.72 million). This new fund includes a significant £20 million (nearly €23.34 million) cornerstone commitment from British Patient Capital and the National Security Strategic Investment Fund, positioning Episode 1 to

The best Articles in our Network

Previous
Next